Avalon Holdings Corporation (AWX)

Ligand Pharmaceuticals Revenue

Avalon Holdings had revenue of $16.07M in the quarter ending March 31, 2025, a decrease of -14.79%. This brings the company's revenue in the last twelve months to $81.01M, down -0.38% year-over-year. In the year 2024, Avalon Holdings had annual revenue of $83.80M with 3.58% growth.

• Revenue (ttm): $81.01M
• Revenue Growth: -0.38%
• P/S Ratio: 0.12
• Revenue / Employee: $91,842
• Employees: 882
• Market Cap: 10.06M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	83.80M	2.90M	3.58%
Dec 31, 2023	80.90M	-281.00K	-0.35%
Dec 31, 2022	81.18M	10.80M	15.34%
Dec 31, 2021	70.38M	11.66M	19.86%
Dec 31, 2020	58.72M	-9.64M	-14.10%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.